Sun Pharma, Teva to settle patent suit tied to acid-reflux med for $2.15B

06/13/2013 | Reuters

Teva Pharmaceutical Industries and Sun Pharmaceutical Industries agreed to settle a patent-infringement lawsuit connected to Pfizer and Takeda Pharmaceutical's acid-reflux treatment Protonix for $2.15 billion. The two makers of generic drugs are accused of marketing a copy of an existing treatment with unexpired patents. "It is an important milestone, setting a 'book-end' case for the industry," said Bernstein Research analyst Aaron Gal. "It will serve to encourage patent settlements."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX